Liaoning Chengda BiotechnologyLtd Management
Management criteria checks 3/4
Liaoning Chengda BiotechnologyLtd's CEO is Yu Mao, appointed in Jan 2022, has a tenure of 2.92 years. directly owns 0.004% of the company’s shares, worth CN¥484.07K. The average tenure of the management team and the board of directors is 2.9 years and 3.2 years respectively.
Key information
Yu Mao
Chief executive officer
CN¥2.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.9yrs |
| CEO ownership | 0.004% |
| Management average tenure | 2.9yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
CEO
Yu Mao (44 yo)
2.9yrs
Tenure
CN¥2,157,900
Compensation
Mr. Yu Mao is General Manager of Liaoning Chengda Biotechnology Co.,Ltd. from January 26, 2022. He was Deputy General Manager of Liaoning Chengda Biotechnology Co.,Ltd.from November 29, 2021 to January 25...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 2.9yrs | CN¥2.16m | 0.0044% CN¥ 484.1k | |
| Deputy GM | 2.9yrs | CN¥1.07m | 0.0012% CN¥ 134.0k | |
| Deputy GM & Chief Scientist | no data | CN¥1.23m | no data | |
| Deputy GM & Director | 4.7yrs | CN¥1.50m | 0.0024% CN¥ 269.2k | |
| Deputy General Manager | no data | CN¥2.12m | 0.13% CN¥ 14.1m | |
| Deputy General Manager | 2.9yrs | CN¥1.26m | 0.087% CN¥ 9.7m |
2.9yrs
Average Tenure
50yo
Average Age
Experienced Management: 688739's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | no data | CN¥2.16m | 0.0044% CN¥ 484.1k | |
| Deputy GM & Director | 1.6yrs | CN¥1.50m | 0.0024% CN¥ 269.2k | |
| Independent Director | 4.8yrs | CN¥96.00k | 0.0049% CN¥ 538.3k | |
| Independent Director | 4.8yrs | CN¥96.00k | no data | |
| Chairman of the Supervisory Board | 1.6yrs | no data | no data | |
| Director | 1.6yrs | no data | no data | |
| Chairman of the Board | 14.1yrs | no data | 0.0071% CN¥ 785.4k | |
| Independent Director | 4.8yrs | CN¥96.00k | no data | |
| Director | 1.6yrs | no data | no data | |
| Employee Representative Supervisor | no data | no data | no data |
3.2yrs
Average Tenure
46.5yo
Average Age
Experienced Board: 688739's board of directors are considered experienced (3.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 09:03 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Liaoning Chengda Biotechnology Co.,Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhu Chen | Citic Securities Co., Ltd. |
| Yizhang Zhu | Citic Securities Co., Ltd. |